Victrex (LON:VCT) Sets New 12-Month Low – Here’s What Happened

by · The Cerbat Gem

Victrex plc (LON:VCT – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 823 ($10.59) and last traded at GBX 831 ($10.69), with a volume of 26693 shares traded. The stock had previously closed at GBX 852 ($10.96).

Analysts Set New Price Targets

Separately, Berenberg Bank decreased their price objective on Victrex from GBX 1,491 ($19.19) to GBX 1,290 ($16.60) and set a “hold” rating for the company in a report on Wednesday, August 28th.

View Our Latest Report on VCT

Victrex Stock Performance

The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99. The stock has a market capitalization of £725.83 million, a PE ratio of 2,434.29, a P/E/G ratio of 1.92 and a beta of 0.69. The business’s fifty day moving average price is GBX 915.34 and its 200-day moving average price is GBX 1,077.35.

Insider Transactions at Victrex

In related news, insider Jane Toogood bought 508 shares of the stock in a transaction that occurred on Tuesday, September 24th. The shares were acquired at an average cost of GBX 937 ($12.06) per share, with a total value of £4,759.96 ($6,125.29). In related news, insider Jakob Sigurdsson bought 2,000 shares of the stock in a transaction dated Friday, August 30th. The stock was bought at an average price of GBX 1,037 ($13.34) per share, with a total value of £20,740 ($26,688.97). Also, insider Jane Toogood acquired 508 shares of the company’s stock in a transaction dated Tuesday, September 24th. The shares were bought at an average cost of GBX 937 ($12.06) per share, with a total value of £4,759.96 ($6,125.29). Over the last quarter, insiders have bought 4,611 shares of company stock valued at $4,549,949. 1.64% of the stock is currently owned by company insiders.

Victrex Company Profile

(Get Free Report)

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.

Read More